Oncology & Cancer

Aspirin may cut mortality in nonmetastatic prostate cancer

(HealthDay)—Daily aspirin use, even at low doses, may reduce mortality among men with high-risk nonmetastatic prostate cancer, according to research published online Oct. 20 in the Journal of Clinical Oncology.

Oncology & Cancer

Benefit of aggressive prostate CA Tx weakens as comorbidity rises

(HealthDay)—For men with early-stage prostate cancer, the cancer-specific survival benefit associated with aggressive prostate cancer treatment is reduced with increasing comorbidity, according to a study published online ...

Oncology & Cancer

Clinical trials show promise for prostate cancer drug

A 30 percent reduction in mortality risk is one of the impressive results achieved in a global clinical drug trial for the treatment of prostate cancer. The full trial data are due to be presented today at one of the world´s ...

Oncology & Cancer

Statin use linked to lower prostate cancer death risk

(HealthDay)—Prostate cancer patients who take the cholesterol-lowering drugs known as statins appear to face a lower risk of death from their disease, new Canadian research suggests.

Oncology & Cancer

Weight at time of diagnosis linked to prostate cancer mortality

Men who are overweight or obese when they are diagnosed with prostate cancer are more likely to die from the disease than men who are of healthy weight, according to a Kaiser Permanente study published today in the journal ...

page 5 from 8